
    
      The enrolled population will include both, virologically-confirmed (VC) dengue cases and
      subjects not having experienced a VC dengue infection (control subjects) from the first Proof
      of Concept efficacy study conducted in Thailand Analyses for correlates will be performed on
      samples collected in the context of the first proof of concept efficacy study. Sequencing of
      dengue viruses will also be done on samples collected within the same context. Immunogenetic
      testing will be performed on saliva samples collected at the study enrollment visit.

      No intervention or vaccine will be provided or administered as part of this study.
    
  